Biomarker and DNA Collection in Subjects Participating in Protocol 22003
NCT00892580
·
clinicaltrials.gov ↗
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Fragile X Syndrome
Interventions
DRUG:
STX209
Sponsor
Seaside Therapeutics, Inc.